Prenatal adverse life events increase the risk for atopic diseases in children, which is enhanced in the absence of a maternal atopic predisposition - 27/06/14
, Peter D. Sly, MD b, Louis A. Schmidt, PhD c, Ryan J. van Lieshout, MD, PhD d, John Bienenstock, MD e, Patrick G. Holt, PhD f, Petra C. Arck, MD a, ⁎ 
Abstract |
Background |
There is evidence to suggest an association between prenatal maternal stress and the development of asthma or other atopic diseases in offspring. Yet, insights on the lasting effect of multiple, common prenatal stressors are rare, and the effects of prenatal timing are poorly understood. Further, it remains elusive if prenatal life events modify the risk for atopic diseases in the context of a parental predisposition to atopy.
Objective |
We tested whether women's experiences of common, adverse life events during the first or second half of pregnancy predicted the risk of developing atopic diseases in their children and whether a reported parental atopic disease moderated this association.
Methods |
We calculated the odds of a child developing asthma, eczema, and/or allergic rhinitis at ages 6 or 14 years, depending on maternal prenatal exposure to negative life events in a sample of 1587 children from the Western Australian Pregnancy Cohort (Raine) Study by using multivariable logistic regression.
Results |
We observed that the likelihood of asthma and eczema at age 14 years was significantly increased in children of mothers who had experienced adverse life events during the second half of gestation (1 life event: adjusted odds ratio for asthma, 2.08 [95% CI, 1.22-3.54]). A stronger increase in the odds to develop asthma upon prenatal life events was present in children of mothers without asthma compared with mothers with asthma.
Conclusions |
Maternal adverse life events during the second half of gestation are linked to an increased risk for the development of atopic disorders, asthma, and eczema, in the case of asthma, particularly in the absence of a maternal asthma.
Le texte complet de cet article est disponible en PDF.Key words : Atopic disease, eczema, asthma, allergic rhinitis, negative life events, prenatal programming, child, pregnancy
Abbreviation used : OR
Plan
| Financial support to address the statistical analyses presented herein was provided by the Alexander von Humboldt Foundation, the Excellence Initiative of the Hamburg Foundation for Research and the Association for Prevention and Information for Allergy and Asthma (Praeventions- und Informationsnetzwerk Allergie/Asthma eingetragener Verein [Pina]). |
|
| Disclosure of potential conflicts of interest: I. R. V. Hartwig has received research support from the Excellence Initiative of Hamburg, Foundation for Research; and has received a 1-year scholarship from the Association for Prevention and Information for Allergy and Asthma. J. Bienenstock has received consultancy fees from Pfizer and Abbott Nutrition Canada; has received research support from Abbott Nutrition and BioGaia. P. C. Arck has received research support from the Excellence Initiative of Hamburg, Foundation for Research and Alexander-von-Humboldt Foundation. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 134 - N° 1
P. 160 - juillet 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
